Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
fosfomycin trometamol, Quantity: 5.631 g
Mayne Pharma International Pty Ltd
fosfomycin trometamol
Granules
Excipient Ingredients: saccharin; sucrose; Flavour
Oral
1
(S4) Prescription Only Medicine
MONUROL is indicated only for the treatment of acute uncomplicated lower urinary tract infections (acute cystitis) in females above 12 years of age caused by the following susceptible pathogens: Escherichia coli or, Enterococcus faecalis.,MONUROL is not indicated for the treatment of pyelonephritis or perinephric abscess or where resistance is likely (previous treatment failure, infection due to non-susceptible organism).,Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to MONUROL. However, therapy may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. Consideration should be given to the relevant clinical guidelines on the appropriate use of antibacterial agents.
Visual Identification: White granules for oral solution; Container Type: Sachet; Container Material: Al laminated with PE/paper; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-09-04
MONUROL ® 1 MONUROL ® _Fosfomycin trometamol _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about MONUROL. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking MONUROL against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT MONUROL IS USED FOR MONUROL contains the active ingredient fosfomycin trometamol and it belongs to a group of medicines called antibiotics. MONUROL IS ONLY USED TO TREAT UNCOMPLICATED INFECTIONS OF THE BLADDER IN FEMALES. IT WORKS BY KILLING BACTERIA WHICH CAN CAUSE INFECTIONS. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. MONUROL is not addictive. It is available only with a doctor's prescription. BEFORE YOU TAKE MONUROL _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE MONUROL IF YOU: • are allergic to fosfomycin trometamol or any of the other ingredients listed at the end of this leaflet • have severe kidney problems (creatinine clearance below 10 ml/min) • are undergoing haemodialysis. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. DO NOT GIVE THIS MEDICINE TO A CHILD UNDER THE AGE OF 12 YEARS. Safety and effectiveness in children younger than 12 years have not been established. DO NOT TAKE THIS MEDICINE AFTER THE EXPIRY DATE PRINTED ON THE PACK OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or is damaged, return it to your pharmacist for disposal. IF YOU ARE NOT SURE WHETHER YOU SHOULD START TAKING THIS MEDICINE, TALK TO YOUR DOCTO Izlasiet visu dokumentu
v 2.0 1 AUSTRALIAN PRODUCT INFORMATION MONUROL (FOSFOMYCIN) GRANULES FOR ORAL SOLUTION 1. NAME OF THE MEDICINE Fosfomycin trometamol 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One sachet of MONUROL granules for oral solution contains 5.631 g of fosfomycin trometamol equivalent to 3.0 g fosfomycin. Fosfomycin trometamol is a white or nearly white crystalline powder. It is very soluble in water, slightly soluble in 95% methanol and ethanol, almost insoluble in anhydrous acetone, in ether and in chlorinated solvents. Excipients with known effect: MONUROL contains sugars (as sucrose) and saccharin. For the full list of excipients, see _ section 6.1 List of Excipients_ . 3. PHARMACEUTICAL FORM MONUROL contains 3 g fosfomycin (as fosfomycin trometamol), presented as white granules for oral solution in single use sachet. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS MONUROL is indicated only for the treatment of acute uncomplicated lower urinary tract infections (acute cystitis) in females above 12 years of age caused by the following susceptible pathogens: Enterobacteriaceae (including _Escherichia coli_ ), _Enterococcus _ _faecalis_ . MONUROL is not indicated for the treatment of pyelonephritis or perinephric abscess or where resistance is likely (previous treatment failure, infection due to non-susceptible organism). Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to MONUROL. However, therapy may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. Consideration should be given to the relevant clinical guidelines on the appropriate use of antibacterial agents. v 2.0 2 4.2. DOSE AND METHOD OF ADMINISTRATION The recommended dose for the treatment of acute uncomplicated lower urinary tract infections (acute cystitis) is a single MONUROL 3 g sachet in women above 12 years of age. MONUROL is for oral administration. It should be taken on an empty Izlasiet visu dokumentu